The land of microcap stocks is not my preferred hunting ground; there
are way too many hype-driven stories and way too few real diamonds in
the rough to make the panning process worthwhile. Even so, ChromaDex (OTCQB:CDXC)
looks like a potential exception to the rule worthy of a closer look. I
think the company's basic business strategy of pursuing high-potential
ingredients for supplements and other nutritional products is a sound
one. For better or worse, the pharmaceutical implications of some of
these products could capture investor attention and really ignite the
stock for stretches at a time.
All of that said, I won't go any
further than to say this looks interesting and worthy of further
investigation for investors who can take on the risks. ChromaDex will
almost certainly need to raise more funds and I don't see how the
company can produce long-term value without eventually taking on a more
significant internal R&D strategy. Moreover, given the nature of the
large float and active volume, this is a stock that can I see easily
getting moved around by news and rumor.
Click the link to continue:
ChromaDex Looks Interesting, But Highly Speculative
No comments:
Post a Comment